Detalhe da pesquisa
1.
Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction.
Sci Rep
; 13(1): 9825, 2023 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37330528
2.
Screening Strategies for the Discovery of Ion Channel Monoclonal Antibodies.
Curr Protoc Pharmacol
; 82(1): e44, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30168908
3.
Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
MAbs
; 10(1): 104-117, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28952876
4.
Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple Assays.
J Biomol Screen
; 21(1): 24-34, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26450103
5.
Versatility of homogeneous time-resolved fluorescence resonance energy transfer assays for biologics drug discovery.
J Biomol Screen
; 20(4): 508-18, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381254
6.
Application of the mirrorball high-sensitivity cytometer to multiplexed assays for antibody drug discovery.
J Biomol Screen
; 20(4): 536-44, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381256